Search This Blog

Wednesday, May 29, 2019

Puma Biotechnology (PBYI) PT Lowered to $24 at Goldman Sachs

Analyst Paul Choi lowered the price target on Puma Biotechnology (NASDAQ: PBYI) to $24.00 (from $29.00) while maintaining a Neutral rating.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.